SILO - Latest News

Silo Pharma, Inc. (SILO), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $2.9M. Beta to the broader market is 0.80.

The article list below shows the most recent SILO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent SILO Headlines

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment

globenewswire.com - Aug 18, 2026

Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead the

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

globenewswire.com - Aug 6, 2026

Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adopt

Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Expands By 795.6%

defenseworld.net - Jul 27, 2026

Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) was the recipient of a large increase in short interest in July.

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

globenewswire.com - Jul 21, 2026

Silo continues to add technology assets as it expands its AI business and further develops its lead PTSD therapeutic candidate

Silo Pharma Unit Eyes Faster AI Agent Development Through AMD Partnership

benzinga.com - Jul 14, 2026

Silo Pharma Incs (NASDAQ:SILO) announced on Tuesday that its wholly owned subsidiary, QwikAgents, has been accepted into Advanced Micro Devices Inc. '

How News Affects SILO Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track SILO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked SILO news questions

What is the latest SILO news headline?

The most recent SILO headline (Aug 18, 2026) is "Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the SILO news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What SILO news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual SILO options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.